Head-to-head · WeighScore
Eloria vs Eve
The verdict
Eve takes it — 66.3/100 to 65.6/100, but only just.
Eve grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual… Eloria is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eloria | Eve |
|---|---|---|
| WeighScore | 65.6/100 | 66.3/100 |
| Grade | C | C |
| Scorecard rank | #214 | #189 |
| Semaglutide | $179/mo (starting dose, plus a separate fee, compounded) | $195/mo (compounded) |
| Tirzepatide | Not disclosed | $195/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #214 · C
Strengths
- Compounded GLP-1 injections from $179/mo and oral dissolving tablets from $249/mo, with no membership or hidden fees
- Also offers brand Wegovy (pill or injection) on a $99/mo membership plus medication cost
- Board-certified providers (via Arora Health & Aesthetics) and US-licensed pharmacies
- HSA/FSA accepted, free shipping on every order, and 24/7 support
- Full published compliance suite (Terms, Privacy, Refund, Shipping, Physician Code of Conduct, Consent to Telehealth)
Where it loses points
- Compounded medications are not FDA-approved - not brand Ozempic, Zepbound, or Mounjaro
- State availability varies and is not published - only where providers are licensed and pharmacies can dispense
- The compounding pharmacy partner is not named (US-licensed pharmacies only)
- No LegitScript certification displayed
- Brand Wegovy uses a separate $99/mo membership-plus-medication-cost model
Graded #189 · C
Strengths
- Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
- Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
- LegitScript Certified with a verifiable ID
- Publishes the FDA compounded-medication disclaimer
- Oral sublingual semaglutide offered alongside injectable
Where it loses points
- Full states-served list not disclosed publicly
- 503A pharmacy partner not named, and 503A vs 503B status not specified
- Named medical director / clinical leadership not disclosed
- Corporate legal entity not disclosed
- Governing law / arbitration venue not stated
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.